• Explore /
  • Poster
  • / Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.

Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.

Abstract Poster

Authors

Suresh Ramalingam

Suresh S. Ramalingam

The Winship Cancer Institute of Emory University, Atlanta, GA

Suresh S. Ramalingam , Bojan Zaric , Timur Ceric , Tudor E. Ciuleanu , James F. Spicer , Igor Bondarenko , Dmitry Komov , Enriqueta Felip , Enric Carcereny , Joachim Von Pawel , Miroslav Samarzija , Thierry Pieters , Michael Schenker , Manuel R. Modiano , Rodryg Ramlau , Marianna Koczywas , Florentina Teofilovici , Ilker Yalcin , Vojislav M. Vukovic , Dean Fennell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01798485

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS8118^)

DOI

10.1200/jco.2014.32.15_suppl.tps8118

Abstract #

TPS8118^

Poster Bd #

299A

Abstract Disclosures

Similar Posters

First Author: Dean Anthony Fennell

First Author: Yuangyuan Zhao

First Author: Kiyotaka Yoh

First Author: Harry J.M. Groen